SlideShare a Scribd company logo
Healthcare Operations Management
Module Title : Healthcare Operations Management
Level of Study : CIQ Level -7/ Postgraduate
By Dr.Syed Raza, MD, MRCP,FRCP,CCT,FACC,FESC
PG Dip. HCM , American Board in Medical Quality
Objectives to cover (LO3)
• 1.Clinical and non -clinical metrics to enhance organizational
performance in healthcare setting
• 2. Patient satisfaction and process enhancement leading to cost
benefits
• 3. Review of performance indicators
• 4. Develop a model and recommend solutions for enhanced
performance
• 5. Team work
Process and outcome measures
Measures of healthcare performance can be process or outcomes
measures.
– Process measures answer the question, “Are we doing the right
things?”
– Outcomes measures answer the question, “Are we doing the right
things well?”
KPIs vs. Metrics: Know the Difference
• A key performance indicator is used to measure performance and
success.
• A metric is nothing more than a number within a KPI that helps track
performance and progress.
Key Performance Indicator
• Key Performance Indicator measures performance or outcome .
• In a healthcare setting this is achieved by using clinical and non-
clinical metrics
Key Performance Indicator
Common metrics in Healthcare
• Average Length of Stay
• Time to service.
• Hospital Incidents.
• Patient Satisfaction.
• Physician performance.
• Patient readmission rate.
• Operating Margin.
• Bed Occupancy Rate.
Common metrics in Healthcare
• Patient Drug Cost per stay
• Medical Utilization rate
• Turn around time for medical reports
• Waiting time
• Staff to patient ratio
• Cancelled / missed appointments
A KPI should be based on the following
principles:
• Implement a specific objective for each KPI.
• You must be able to measure your progress (or lack thereof) over a
specific period of time.
• The best KPIs are those that can be attained with a reasonable level
of effort.
• Results (such as the metrics you measure) should be related to your
goals.
• Indicators can measure structures, processes or outcomes of
health care.
• Clinical performance indicators are usually based on rates
measured or significant (critical) incidents in patient population
(ie. using clinical metrics)
• Non-Clinical performance indicators are based on metrics
that measures service delivery, operational cost, profit etc.
What is hospital quality metrics ?
Hospital quality metrics are a set of standards developed by CMS to
quantify healthcare processes, patient outcomes, and organizational
structures.
Examples of clinical metrics in KPI
• Average Length of Stay.
• Hospital Incidents
• Patient Satisfaction.
• Physician performance.
• Patient readmission rate
Examples of non-clinical metrics
• Hospital length of stay
• Bed occupancy rate
• Operational cost
• Profit margin
Sentinel Event Indicators
An adverse sentinel event is defined as “an unexpected occurrence-
involving death or serious physical or psychological injury, or the risk
thereof”
Rate based indicators
• Unlike sentinel event indicators that identify single occurrences, rate-based
indicators are used to monitor many events or a process over a specified
period of time.
Caesarean sections
vaginal births after C-section
Unexpected deaths
Wound infections
• Rate-based indicators measure the proportion of occurrences or events in
relation to the population at risk. To determine the rate, divide the number
of occurrences (numerator) by the number of individuals at risk
(denominator)
Required performance measures (JCIA)
• 1. All adverse events or patterns of adverse events occurring during
anesthesia use, including sedation of patients while the patients are
conscious
• 2. Processes and outcomes related to behavior management, including
(when possible) the perceptions of the patients or individuals served, their
families, and the hospital’s clinical staff
• 3. Processes and outcomes related to the use of restraint and seclusion
• 4. Appropriateness of admission and continued stays (i.e., utilization
management activities)
• 5. Significant adverse drug reactions
Required performance measures : Contd1
• 6. Processes and outcomes related to medication usage
• 7. Processes and outcomes related to surgery and invasive or
noninvasive procedures
• 8. Processes and outcomes related to blood usage
• 9. Appropriateness, completeness, and timeliness of health record
documentation
• 10.Deficiencies, problems, failures, and user errors in safety
management, life safety management, equipment management, and
utilities management
Required performance measures : Contd2
• 11. Information solicited from patients and mdividuals served, their
families, hospital staff members, and others about how well the
organization is meeting needs and expectations, the level of satisfaction
with the organization, and areas where the organization could improve
• 12. Competence of all staff, including licensed independent practitioners
• 13. Risk-management activities
• 14. Quality control activities covering the following services: clinical
laboratory. nutrition, equipment used in administering medication, and
pharmaceutical equipment used to prepare medication (only those
services provided in the organization)
PATIENT CENTERED STANDARDS
• Access to Care & Continuity of Care (ACC)
• • Patient & Family Rights (PFR).
• • Assessment of Patient (AOP)
• • Care of Patient (COP).
• • Patient & Family Education (PFE)
Healthcare Organization Management
Standards
• Quality Improvement and Patient Safety (QPS)
• • Prevention and Control of Infection (PCI)
• • Governance, Leadership and Direction (GLD)
• • Facility Management and Safety (FMS)
• • Staff Qualification and Management (SQE)
• • Management of Information (MOI)
Goal Metrics
Metrics that organizations utilize to measure performance goal using
or testing certain strategy or planning.
Qualitative Metrics
Quantitative Metrics
Actionable Metrics
Informational Metrics
Vanity Metrics
The seven groupings of outcome measures CMS
uses to calculate hospital quality are some of the
most common in healthcare
• #1: Mortality
• #2: Safety of Care
• #3: Readmissions
• #4: Patient Experience
• #5: Effectiveness of Care
• #6: Timeliness of Care
• #7: Data Transparency
Why Measure?
• To provide facts by which to manage
• • To take advantage of the reality that people pay more attention to
facts
• • To help make decisions based on fact
• • To help prioritize opportunities for improvement
• • To recognize successes
• • To evaluate performance
Process and Outcomes Measures for
Outpatients with Diabetes MelIittis
• Process measures – Rate of glycosylated hemoglobin testing – Percent
of patients self-monitoring of blood glucose – Rates of dilated
ophthalmoscopic examination – Rates of foot examination
• Outcome measures – Average value of glycosylated hemoglobin
testing – Hospitalization rates – Percentage of patients developing foot
ulcers
Peri-operative Indicators
• Denominator: All patients undergoing inpatient procedures involving anesthesia (defined as
administration of general, spinal, or regional anesthesia or sedation) for which there is a
reasonable expectation that the sedation anesthesia will result in the loss of protective reflexes
for a significant percentage of patients (all settings, purposes, routes) 1. “Focus: Preoperative
patient evaluation, intraoperative and postoperative monitoring, and timely clinical intervention
Numerator: Patients developing a CNS complication occurring within two postprocedure days of
procedures involving anesthesia administration (subcategorized by ASA-PS class, patient age, and
CNS- versus non-CNSrelated procedures” 2. Focus: Same, plus appropriate surgical preparation
“Numerator: Patients developing a peripheral neurological deficit within two postprocedure days
of procedures involving anesthesia administration” 3. “Focus: Preoperative patient evaluation,
intraoperative and postoperative monitoring, and timely clinical intervention Numerator: Patients
developing an acute myocardial infarction within two post procedure days of procedures involving
anesthesia administration [subcategorized by ASA-PS class, patient age, and cardiac- versus
noncardiac-related procedures]” 4. Focus: Same “Numerator. Patients with a cardiac arrest within
two postprocedure days of procedures involving anesthesia administration [subcategorized by
ASA-PS class, patient age, and cardiac-versus noncardiac-related procedures]” 5. Focus Same
“Numerator: Intrahospital mortality of patients within two postprocedure days of procedures
involving anesthesia administration [subcategorized by ASA-PS class and patient age]
Obstetrical care indicators
• . Focus: Prenatal patient evaluation, education, and treatment selection Numerator:
Patients delivered by cesarean section Denominator: All deliveries 7. Focus: Same
Numerator: Patients with vaginal birth after cesarean section (VBAC) Denominator:
Patients delivered with a history of previous cesarean section” 8. Focus: Prenatal patient
evaluation, intrapartum monitoring, and clinical intervention Numerator. Live-born
infants with a birthweight less than 2500 grams Denominator: All live births 9. Focus:
Prenatal patient evaluation, intrapartum monitoring, neonatal patient eva1uatIc and
clinical intervention Numerator. Live-born infants with a birthweight greater than or
equal to 2500 grams, who have at least one of the following: anApgar score of less than 4
at five minutes, a requirement for admission to the neonatal intensive care unit within
one day of delivery for greater than 24 hours, a dinically apparent seizure, or significant
birth trauma Denominator: All five-born infants with a birthweight greater than 2500
grams* 10. Focus: Same “Numerator. Live-born infants with a birthweight greater than
1000 grams and less than 2500 grams who have an Apgar score of less than 4 at five
minutes Denominator: All live-born infants with a birthweight greater than 1000 grams
and less than 2500 gram
Cardiovascular Indicators
• Focus: Extended postoperative stay as a means of assessing multiple aspects of coronary artery bypass graft
(CABG) care Indicator Statement: Patients undergoing isolated CABG procedures: number of days from-
surgery to discharge Focus: Timing of thrombolytic therapy administration Indicator Statement: Patients
admitted through the emergency department who have a principal discharge diagnosis of acute myocardial
infarction (AM I) and ST segment evaluation on their initial electrocardiogram: time from emergency
department arrival to administration of thrombotytic therapy “Focus: Diagnostic accuracy Numerator
Patients with principal discharge diagnosis of congestive heart failure (CHF) with documented etiology
Denomator Patients with principal discharge diagnosis of CHF “Focus: Extended postprocedure Stay as a
means of assessing multiple aspects of percutaneous-transluminal coronary angioplasty (PTCA) care
Indicator Statement: Patients undergoing PTCA: number of days from procedure to discharge “Focus:
Intrahospital mortality as a means of assessing multiple aspects of coronary artery bypass graft (CABG)
patient care Numeratoar Intrahospital mortality of patients undergoing an isolated CABG Denominator
Patients undergoing an iso!ated CABGW “Focus: Intrahospital mortality as a means of assessing multiple
aspects of percutaneous transluminal coronary angioplasty (PTCA) patient care Numerator: lntrahospital
mortality of patients undergoing a PTCA Denominator: Patients undergoing PTCA “Focus: Intrahospital
mortality as a means of assessing multiple aspects of acute myocardial infarction (AMI) patient care
Numerator: Intrahospital mortality of patients with a principal discharge diagnosis of AMI Denominator:
Patients with a principal discharge diagnosis of AMI”
Oncology Indicators
• “Focus: Availability of data for diagnosis and staging Numerator. Patients undergoing resection for
primary cancer of the lung, colon/rectum or female breast for whom a surgical pathology
consultation report is present in the medical record Denominator: Patients undergoing resection
for primary cancer of the female breast, lung, or colon/ rectum. 17. “Focus: Use of staging by
managing physicians Numerator: Patients undergoing resection for primary cancer of the female
breast, or colon/ rectum with stage of tumor designated by a managing physician Denominator:
Patients undergoing resection for primary cancer of the female breast, lung, of colon/rectums 18.
“Focus: Use of tests critical for prognosis and clinical management of female breast cancer
Numerator. Female patients with American Joint Committee on Cancer (AJCC) Stage I or greater
primary breast cancer who, after initial biopsy or resection, have estrogen receptor analysis
results in the medical record Denominator Female patients with Stage I or greater primary breast
cancer undergoing initial biopsy or resection’ 19. “Focus: Effectiveness of preoperative diagnosis
and staging Numerator. Patients with nonsmall cell primary lung cancer undergoing thoracotomy
with complete surgical resection of tumor Denominator Patients with nonsmall cell primary lung
cancer undergoing thoracotomy 20. “Focus: Comprehensiveness of diagnostic workup Numerator:
Patients undergoing resection of primary cancer of the colon or rectum whose preoperative
evaluation by a managing physician included examination of the entire colon Denominator:
Patients undergoing resection for primary cancer of the colon or rectum.
Medication use indicators
• “Focus: Individualizing dosage Numerator lnpatients 65 years of age or older in whom creatinine clearance
has been estimated or measured Denominator Inpatients 65 years of age or older 27 “Focus liming of
medication administration - - Indicator Statement Patients with selected surgical procedures receiving
intravenous prophylactic antibiotics Timing of prophylactic antibiotic administration 28 “Focus Informing the
patient about the medication - Numerator lnpatients with a discharge diagnosis of insulin-dependent
diabetes mellitus who demonstrate self-blood-glucose monitoring and self-administration of insulin before
discharge or are referred for postdischarge follow-up for diabetes management Denominator: Inpatients
with a discharge diagnosis of insuIin-dependent diabetes 29 a “Focus Monitoring patient response
Numerator. Inpatients receiving digoxin who have no corresponding measure drug level or whose highest
measured level exceeds a specific limit Denominator Inpatients receiving digoxin’ 29b “Focus Monitoring
patient response Numerator lnpatients receiving theophylline who have no corresponding measured drug
level or whose highest measured level exceeds a specific limit Denominator Inpatients receiving theophyllin
29 c “Focus Monitoring patient response Numerator: Inpatients receiving phenytoin who have no
corresponding measured drug level or whose highest measured level exceeds a specific limit Denominator
lnpatient receiving phenytoin ” 29 d “Focus: Monitoring patient response Numerator: Inpatients receiving
lithium who have no corresponding measured drug level or whose highest measured level exceeds a specific
limit Denominator inpatient receiving lithium” 30 “Focus Reviewing complete drug regimen Indicator
Statement: Inpatients Number of prescribed medications at discharge”
Infection control indicators
• Focus: Surgical site infection Numerator: Selected inpatient and
outpatient surgical procedures complicated by a surgical site infection
Denominator: l’1umber of selected inpatient and outpatient surgical
procedures” 2. Focus: Ventilator pneumonia Numerator: Ventilated
inpatients who develop pneumonia Denominator: Inpatient ventilator
days 3. Focus: Concurrent surveillance of primary bloodstream
infection Numerator: Inpatients with a central or umbilical line who
develop primary bloodstream infection Denominator. Inpatient
central or umbilical line days
Acute Care Indicators
• Device-associated infections in the surgical intensive care unit • Device use
in the surgical intensive care unit (central lines, ventilators, indwelling
urinary catheters) • Surgical site infections • Prophylaxis [antibiotic] usage
for surgical procedures • Total inpatient mortality (10 DRGs and all other
DRGs) • Neonatal mortality (direct admissions and transfers) • Total
perioperative mortality (Within 48 hours of anesthesia, by ASA class) •
Management of pregnancy (cesarean sections and VBACs) • Unscheduled
readmissions (within 15 and 31 days for 6 DRGs) • Unscheduled admissions
following ambulatory procedure (inpatient and observation admissions) •
Unscheduled returns to an intensive care unit Unscheduled returns to the
operating room • Isolated CABG perioperative mortality (by ASA class,
observed and expected) • Physical restraint use (total events, patients with
multiple events, duration, reasons) • Documented falls (10 measures) •
Complications following sedation and analgesia (4 areas)
Acute care ambulatory indicators
• • Unscheduled returns to the emergency department for same or
related conçiition within the specified time frame (within 24 48
and/or 72 hours)
• Registered patients’ time in the ED
• ED x-ray discrepancies requiring a change in patient management
• Registered patients leaving the ED before completing treatment
Cancellation of ambulatory procedures on the day of the procedure
Patient satisfaction
What should be measured ?
• What are the customers’ expectations?
• What aspects of customer satisfaction should be measured? How can
these aspects be measured?
• For outcomes related to key quality attributes: What evidence is
available to demonstrate whether the care or service provided have
met the customers’ expectations and/or current professional
standards?
• Which outcomes are most important to our customers?
• How can these be measured ?
The Top Five Recommendations for
Improving the Patient Experience of Care
• #1: Use Patient Satisfaction as a Balance Measure—Not a
Driver for Outcomes
• #2: Evaluate Entire Care Teams—Not Individual Providers
• #3: Use Healthcare Analytics to Understand and Act on Data
• #4: Leverage Innovative Technology
• #5: Improve Employee Engagement
Performance Indicators for nursing
CLO3  KEY PERFORMANCE  INDICATORS.pptx

More Related Content

Similar to CLO3 KEY PERFORMANCE INDICATORS.pptx

CLINICAL AUDIT
CLINICAL AUDITCLINICAL AUDIT
CLINICAL AUDIT
S A Tabish
 
improving quality and safety in patient care delivery .
 improving quality and safety in patient care delivery . improving quality and safety in patient care delivery .
improving quality and safety in patient care delivery .
Ahamed Masooth mohamed
 
The Functional Health Patterns: Nursing Diagnosis.ppt
The Functional Health Patterns: Nursing Diagnosis.pptThe Functional Health Patterns: Nursing Diagnosis.ppt
The Functional Health Patterns: Nursing Diagnosis.ppt
Rehmat18
 
Final
FinalFinal
Clinical audit for the enlightened ian callanan hslg conference 2013
Clinical audit for the enlightened ian callanan hslg conference 2013Clinical audit for the enlightened ian callanan hslg conference 2013
Clinical audit for the enlightened ian callanan hslg conference 2013
hslgcommittee
 
How to Define Effective and Efficient Real World Trials
How to Define Effective and Efficient Real World TrialsHow to Define Effective and Efficient Real World Trials
How to Define Effective and Efficient Real World Trials
Todd Berner MD
 
How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...
Todd Berner MD
 
surgical audit
surgical auditsurgical audit
surgical audit
Ankur Kajal
 
Quality Improvement Presentation (1).pptx
Quality Improvement Presentation (1).pptxQuality Improvement Presentation (1).pptx
Quality Improvement Presentation (1).pptx
mosemsilawy
 
Seminar on evidence based practice
Seminar on evidence based practiceSeminar on evidence based practice
Seminar on evidence based practice
AmritanshuChanchal
 
Advanced practice nurse led clinics March 2010
Advanced practice nurse led clinics March 2010Advanced practice nurse led clinics March 2010
Advanced practice nurse led clinics March 2010
Australian Primary Health Care Nurses Association
 
Quality Orientation.pptx
Quality Orientation.pptxQuality Orientation.pptx
Quality Orientation.pptx
KimTurner50
 
Medical audit
Medical auditMedical audit
Medical audit
Seema Verma
 
clinical-pathway-_1_.pptaya.ppt2.ppt
clinical-pathway-_1_.pptaya.ppt2.pptclinical-pathway-_1_.pptaya.ppt2.ppt
clinical-pathway-_1_.pptaya.ppt2.ppt
AmlOmar3
 
Audit in anaesthesia
Audit in anaesthesiaAudit in anaesthesia
Audit in anaesthesia
Dr. Ravikiran H M Gowda
 
Medical audit
Medical auditMedical audit
Medical audit
Dr.Salil Choudhary
 
Surgical Audit
Surgical AuditSurgical Audit
Surgical Audit
akinbodeog
 
Evaluation of the implementation of Lester tool 2014 in Psychiatric Inpatient...
Evaluation of the implementation of Lester tool 2014 in Psychiatric Inpatient...Evaluation of the implementation of Lester tool 2014 in Psychiatric Inpatient...
Evaluation of the implementation of Lester tool 2014 in Psychiatric Inpatient...
NHS Improving Quality
 
surgical audit
surgical auditsurgical audit
surgical audit
soori14386
 
U of T Department of Family & Community Medicine PEARLS 2014
U of T Department of Family & Community Medicine PEARLS 2014U of T Department of Family & Community Medicine PEARLS 2014
U of T Department of Family & Community Medicine PEARLS 2014
Health Quality Ontario (HQO)
 

Similar to CLO3 KEY PERFORMANCE INDICATORS.pptx (20)

CLINICAL AUDIT
CLINICAL AUDITCLINICAL AUDIT
CLINICAL AUDIT
 
improving quality and safety in patient care delivery .
 improving quality and safety in patient care delivery . improving quality and safety in patient care delivery .
improving quality and safety in patient care delivery .
 
The Functional Health Patterns: Nursing Diagnosis.ppt
The Functional Health Patterns: Nursing Diagnosis.pptThe Functional Health Patterns: Nursing Diagnosis.ppt
The Functional Health Patterns: Nursing Diagnosis.ppt
 
Final
FinalFinal
Final
 
Clinical audit for the enlightened ian callanan hslg conference 2013
Clinical audit for the enlightened ian callanan hslg conference 2013Clinical audit for the enlightened ian callanan hslg conference 2013
Clinical audit for the enlightened ian callanan hslg conference 2013
 
How to Define Effective and Efficient Real World Trials
How to Define Effective and Efficient Real World TrialsHow to Define Effective and Efficient Real World Trials
How to Define Effective and Efficient Real World Trials
 
How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...
 
surgical audit
surgical auditsurgical audit
surgical audit
 
Quality Improvement Presentation (1).pptx
Quality Improvement Presentation (1).pptxQuality Improvement Presentation (1).pptx
Quality Improvement Presentation (1).pptx
 
Seminar on evidence based practice
Seminar on evidence based practiceSeminar on evidence based practice
Seminar on evidence based practice
 
Advanced practice nurse led clinics March 2010
Advanced practice nurse led clinics March 2010Advanced practice nurse led clinics March 2010
Advanced practice nurse led clinics March 2010
 
Quality Orientation.pptx
Quality Orientation.pptxQuality Orientation.pptx
Quality Orientation.pptx
 
Medical audit
Medical auditMedical audit
Medical audit
 
clinical-pathway-_1_.pptaya.ppt2.ppt
clinical-pathway-_1_.pptaya.ppt2.pptclinical-pathway-_1_.pptaya.ppt2.ppt
clinical-pathway-_1_.pptaya.ppt2.ppt
 
Audit in anaesthesia
Audit in anaesthesiaAudit in anaesthesia
Audit in anaesthesia
 
Medical audit
Medical auditMedical audit
Medical audit
 
Surgical Audit
Surgical AuditSurgical Audit
Surgical Audit
 
Evaluation of the implementation of Lester tool 2014 in Psychiatric Inpatient...
Evaluation of the implementation of Lester tool 2014 in Psychiatric Inpatient...Evaluation of the implementation of Lester tool 2014 in Psychiatric Inpatient...
Evaluation of the implementation of Lester tool 2014 in Psychiatric Inpatient...
 
surgical audit
surgical auditsurgical audit
surgical audit
 
U of T Department of Family & Community Medicine PEARLS 2014
U of T Department of Family & Community Medicine PEARLS 2014U of T Department of Family & Community Medicine PEARLS 2014
U of T Department of Family & Community Medicine PEARLS 2014
 

More from SYEDRAZA56411

The Art and Science of Management of Hypertension
The Art and Science of Management of Hypertension The Art and Science of Management of Hypertension
The Art and Science of Management of Hypertension
SYEDRAZA56411
 
Underuse and Misuse of Newer Anti diabetic Medications in Patients at Risk an...
Underuse and Misuse of Newer Anti diabetic Medications in Patients at Risk an...Underuse and Misuse of Newer Anti diabetic Medications in Patients at Risk an...
Underuse and Misuse of Newer Anti diabetic Medications in Patients at Risk an...
SYEDRAZA56411
 
Heart Failure Management -in light of Evidence Based Medicine and Guidelines
Heart Failure Management -in light of Evidence Based Medicine and Guidelines Heart Failure Management -in light of Evidence Based Medicine and Guidelines
Heart Failure Management -in light of Evidence Based Medicine and Guidelines
SYEDRAZA56411
 
ECG TEACHING AGU 2021.pptx
ECG TEACHING AGU 2021.pptxECG TEACHING AGU 2021.pptx
ECG TEACHING AGU 2021.pptx
SYEDRAZA56411
 
Role of Dapagliflozin in the management of Diabetes and prevention of cardiac...
Role of Dapagliflozin in the management of Diabetes and prevention of cardiac...Role of Dapagliflozin in the management of Diabetes and prevention of cardiac...
Role of Dapagliflozin in the management of Diabetes and prevention of cardiac...
SYEDRAZA56411
 
Hypertension in Athletes
Hypertension in Athletes Hypertension in Athletes
Hypertension in Athletes
SYEDRAZA56411
 
Sleep Apnea and its impact on cardiovascular system
Sleep Apnea and its impact on cardiovascular system Sleep Apnea and its impact on cardiovascular system
Sleep Apnea and its impact on cardiovascular system
SYEDRAZA56411
 
Your First Step Towards Healthy Heart
Your  First  Step Towards  Healthy Heart Your  First  Step Towards  Healthy Heart
Your First Step Towards Healthy Heart
SYEDRAZA56411
 
Dyslipidemia -Assessment and management based on evidence
Dyslipidemia -Assessment and management based on evidence  Dyslipidemia -Assessment and management based on evidence
Dyslipidemia -Assessment and management based on evidence
SYEDRAZA56411
 
Getting to the heart of Diabetes
Getting  to the heart of Diabetes Getting  to the heart of Diabetes
Getting to the heart of Diabetes
SYEDRAZA56411
 
ECG BASICS PRESENTATION .pptx
ECG  BASICS  PRESENTATION .pptxECG  BASICS  PRESENTATION .pptx
ECG BASICS PRESENTATION .pptx
SYEDRAZA56411
 
COVID AND HEART.pptx
COVID  AND HEART.pptxCOVID  AND HEART.pptx
COVID AND HEART.pptx
SYEDRAZA56411
 
The science of weight loss
The  science of  weight  loss The  science of  weight  loss
The science of weight loss
SYEDRAZA56411
 
CREDENTIALING AND PRIVILEGING POLICY_.pptx
CREDENTIALING  AND PRIVILEGING POLICY_.pptxCREDENTIALING  AND PRIVILEGING POLICY_.pptx
CREDENTIALING AND PRIVILEGING POLICY_.pptx
SYEDRAZA56411
 
SUDDEN CARDIAC ARREST_.pptx
SUDDEN  CARDIAC  ARREST_.pptxSUDDEN  CARDIAC  ARREST_.pptx
SUDDEN CARDIAC ARREST_.pptx
SYEDRAZA56411
 
COVID WEBINAR 13 June.pptx
COVID WEBINAR  13 June.pptxCOVID WEBINAR  13 June.pptx
COVID WEBINAR 13 June.pptx
SYEDRAZA56411
 
SLEEP APNEA.pptx
SLEEP  APNEA.pptxSLEEP  APNEA.pptx
SLEEP APNEA.pptx
SYEDRAZA56411
 
An Introduction to Teamwork in healthcare
An Introduction to  Teamwork in healthcareAn Introduction to  Teamwork in healthcare
An Introduction to Teamwork in healthcare
SYEDRAZA56411
 
covid-19.pptx
covid-19.pptxcovid-19.pptx
covid-19.pptx
SYEDRAZA56411
 
COVID REHAB N.pptx
COVID REHAB N.pptxCOVID REHAB N.pptx
COVID REHAB N.pptx
SYEDRAZA56411
 

More from SYEDRAZA56411 (20)

The Art and Science of Management of Hypertension
The Art and Science of Management of Hypertension The Art and Science of Management of Hypertension
The Art and Science of Management of Hypertension
 
Underuse and Misuse of Newer Anti diabetic Medications in Patients at Risk an...
Underuse and Misuse of Newer Anti diabetic Medications in Patients at Risk an...Underuse and Misuse of Newer Anti diabetic Medications in Patients at Risk an...
Underuse and Misuse of Newer Anti diabetic Medications in Patients at Risk an...
 
Heart Failure Management -in light of Evidence Based Medicine and Guidelines
Heart Failure Management -in light of Evidence Based Medicine and Guidelines Heart Failure Management -in light of Evidence Based Medicine and Guidelines
Heart Failure Management -in light of Evidence Based Medicine and Guidelines
 
ECG TEACHING AGU 2021.pptx
ECG TEACHING AGU 2021.pptxECG TEACHING AGU 2021.pptx
ECG TEACHING AGU 2021.pptx
 
Role of Dapagliflozin in the management of Diabetes and prevention of cardiac...
Role of Dapagliflozin in the management of Diabetes and prevention of cardiac...Role of Dapagliflozin in the management of Diabetes and prevention of cardiac...
Role of Dapagliflozin in the management of Diabetes and prevention of cardiac...
 
Hypertension in Athletes
Hypertension in Athletes Hypertension in Athletes
Hypertension in Athletes
 
Sleep Apnea and its impact on cardiovascular system
Sleep Apnea and its impact on cardiovascular system Sleep Apnea and its impact on cardiovascular system
Sleep Apnea and its impact on cardiovascular system
 
Your First Step Towards Healthy Heart
Your  First  Step Towards  Healthy Heart Your  First  Step Towards  Healthy Heart
Your First Step Towards Healthy Heart
 
Dyslipidemia -Assessment and management based on evidence
Dyslipidemia -Assessment and management based on evidence  Dyslipidemia -Assessment and management based on evidence
Dyslipidemia -Assessment and management based on evidence
 
Getting to the heart of Diabetes
Getting  to the heart of Diabetes Getting  to the heart of Diabetes
Getting to the heart of Diabetes
 
ECG BASICS PRESENTATION .pptx
ECG  BASICS  PRESENTATION .pptxECG  BASICS  PRESENTATION .pptx
ECG BASICS PRESENTATION .pptx
 
COVID AND HEART.pptx
COVID  AND HEART.pptxCOVID  AND HEART.pptx
COVID AND HEART.pptx
 
The science of weight loss
The  science of  weight  loss The  science of  weight  loss
The science of weight loss
 
CREDENTIALING AND PRIVILEGING POLICY_.pptx
CREDENTIALING  AND PRIVILEGING POLICY_.pptxCREDENTIALING  AND PRIVILEGING POLICY_.pptx
CREDENTIALING AND PRIVILEGING POLICY_.pptx
 
SUDDEN CARDIAC ARREST_.pptx
SUDDEN  CARDIAC  ARREST_.pptxSUDDEN  CARDIAC  ARREST_.pptx
SUDDEN CARDIAC ARREST_.pptx
 
COVID WEBINAR 13 June.pptx
COVID WEBINAR  13 June.pptxCOVID WEBINAR  13 June.pptx
COVID WEBINAR 13 June.pptx
 
SLEEP APNEA.pptx
SLEEP  APNEA.pptxSLEEP  APNEA.pptx
SLEEP APNEA.pptx
 
An Introduction to Teamwork in healthcare
An Introduction to  Teamwork in healthcareAn Introduction to  Teamwork in healthcare
An Introduction to Teamwork in healthcare
 
covid-19.pptx
covid-19.pptxcovid-19.pptx
covid-19.pptx
 
COVID REHAB N.pptx
COVID REHAB N.pptxCOVID REHAB N.pptx
COVID REHAB N.pptx
 

Recently uploaded

NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...
NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...
NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...
BBPMedia1
 
❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Fin...
❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Fin...❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Fin...
❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Fin...
❼❷⓿❺❻❷❽❷❼❽ Dpboss Kalyan Satta Matka Guessing Matka Result Main Bazar chart
 
Lundin Gold Corporate Presentation - June 2024
Lundin Gold Corporate Presentation - June 2024Lundin Gold Corporate Presentation - June 2024
Lundin Gold Corporate Presentation - June 2024
Adnet Communications
 
The latest Heat Pump Manual from Newentide
The latest Heat Pump Manual from NewentideThe latest Heat Pump Manual from Newentide
The latest Heat Pump Manual from Newentide
JoeYangGreatMachiner
 
Profiles of Iconic Fashion Personalities.pdf
Profiles of Iconic Fashion Personalities.pdfProfiles of Iconic Fashion Personalities.pdf
Profiles of Iconic Fashion Personalities.pdf
TTop Threads
 
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
IPLTech Electric
 
IMG_20240615_091110.pdf dpboss guessing
IMG_20240615_091110.pdf dpboss  guessingIMG_20240615_091110.pdf dpboss  guessing
AI Transformation Playbook: Thinking AI-First for Your Business
AI Transformation Playbook: Thinking AI-First for Your BusinessAI Transformation Playbook: Thinking AI-First for Your Business
AI Transformation Playbook: Thinking AI-First for Your Business
Arijit Dutta
 
2024-6-01-IMPACTSilver-Corp-Presentation.pdf
2024-6-01-IMPACTSilver-Corp-Presentation.pdf2024-6-01-IMPACTSilver-Corp-Presentation.pdf
2024-6-01-IMPACTSilver-Corp-Presentation.pdf
hartfordclub1
 
The Steadfast and Reliable Bull: Taurus Zodiac Sign
The Steadfast and Reliable Bull: Taurus Zodiac SignThe Steadfast and Reliable Bull: Taurus Zodiac Sign
The Steadfast and Reliable Bull: Taurus Zodiac Sign
my Pandit
 
The Genesis of BriansClub.cm Famous Dark WEb Platform
The Genesis of BriansClub.cm Famous Dark WEb PlatformThe Genesis of BriansClub.cm Famous Dark WEb Platform
The Genesis of BriansClub.cm Famous Dark WEb Platform
SabaaSudozai
 
Industrial Tech SW: Category Renewal and Creation
Industrial Tech SW:  Category Renewal and CreationIndustrial Tech SW:  Category Renewal and Creation
Industrial Tech SW: Category Renewal and Creation
Christian Dahlen
 
Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...
Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...
Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...
Niswey
 
Part 2 Deep Dive: Navigating the 2024 Slowdown
Part 2 Deep Dive: Navigating the 2024 SlowdownPart 2 Deep Dive: Navigating the 2024 Slowdown
Part 2 Deep Dive: Navigating the 2024 Slowdown
jeffkluth1
 
Prescriptive analytics BA4206 Anna University PPT
Prescriptive analytics BA4206 Anna University PPTPrescriptive analytics BA4206 Anna University PPT
Prescriptive analytics BA4206 Anna University PPT
Freelance
 
Ellen Burstyn: From Detroit Dreamer to Hollywood Legend | CIO Women Magazine
Ellen Burstyn: From Detroit Dreamer to Hollywood Legend | CIO Women MagazineEllen Burstyn: From Detroit Dreamer to Hollywood Legend | CIO Women Magazine
Ellen Burstyn: From Detroit Dreamer to Hollywood Legend | CIO Women Magazine
CIOWomenMagazine
 
欧洲杯投注-欧洲杯投注外围盘口-欧洲杯投注盘口app|【​网址​🎉ac22.net🎉​】
欧洲杯投注-欧洲杯投注外围盘口-欧洲杯投注盘口app|【​网址​🎉ac22.net🎉​】欧洲杯投注-欧洲杯投注外围盘口-欧洲杯投注盘口app|【​网址​🎉ac22.net🎉​】
欧洲杯投注-欧洲杯投注外围盘口-欧洲杯投注盘口app|【​网址​🎉ac22.net🎉​】
concepsionchomo153
 
欧洲杯赌球-欧洲杯赌球买球官方官网-欧洲杯赌球比赛投注官网|【​网址​🎉ac55.net🎉​】
欧洲杯赌球-欧洲杯赌球买球官方官网-欧洲杯赌球比赛投注官网|【​网址​🎉ac55.net🎉​】欧洲杯赌球-欧洲杯赌球买球官方官网-欧洲杯赌球比赛投注官网|【​网址​🎉ac55.net🎉​】
欧洲杯赌球-欧洲杯赌球买球官方官网-欧洲杯赌球比赛投注官网|【​网址​🎉ac55.net🎉​】
valvereliz227
 
Call8328958814 satta matka Kalyan result satta guessing
Call8328958814 satta matka Kalyan result satta guessingCall8328958814 satta matka Kalyan result satta guessing
Call8328958814 satta matka Kalyan result satta guessing
➑➌➋➑➒➎➑➑➊➍
 
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan ChartSatta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results
 

Recently uploaded (20)

NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...
NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...
NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...
 
❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Fin...
❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Fin...❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Fin...
❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Fin...
 
Lundin Gold Corporate Presentation - June 2024
Lundin Gold Corporate Presentation - June 2024Lundin Gold Corporate Presentation - June 2024
Lundin Gold Corporate Presentation - June 2024
 
The latest Heat Pump Manual from Newentide
The latest Heat Pump Manual from NewentideThe latest Heat Pump Manual from Newentide
The latest Heat Pump Manual from Newentide
 
Profiles of Iconic Fashion Personalities.pdf
Profiles of Iconic Fashion Personalities.pdfProfiles of Iconic Fashion Personalities.pdf
Profiles of Iconic Fashion Personalities.pdf
 
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
 
IMG_20240615_091110.pdf dpboss guessing
IMG_20240615_091110.pdf dpboss  guessingIMG_20240615_091110.pdf dpboss  guessing
IMG_20240615_091110.pdf dpboss guessing
 
AI Transformation Playbook: Thinking AI-First for Your Business
AI Transformation Playbook: Thinking AI-First for Your BusinessAI Transformation Playbook: Thinking AI-First for Your Business
AI Transformation Playbook: Thinking AI-First for Your Business
 
2024-6-01-IMPACTSilver-Corp-Presentation.pdf
2024-6-01-IMPACTSilver-Corp-Presentation.pdf2024-6-01-IMPACTSilver-Corp-Presentation.pdf
2024-6-01-IMPACTSilver-Corp-Presentation.pdf
 
The Steadfast and Reliable Bull: Taurus Zodiac Sign
The Steadfast and Reliable Bull: Taurus Zodiac SignThe Steadfast and Reliable Bull: Taurus Zodiac Sign
The Steadfast and Reliable Bull: Taurus Zodiac Sign
 
The Genesis of BriansClub.cm Famous Dark WEb Platform
The Genesis of BriansClub.cm Famous Dark WEb PlatformThe Genesis of BriansClub.cm Famous Dark WEb Platform
The Genesis of BriansClub.cm Famous Dark WEb Platform
 
Industrial Tech SW: Category Renewal and Creation
Industrial Tech SW:  Category Renewal and CreationIndustrial Tech SW:  Category Renewal and Creation
Industrial Tech SW: Category Renewal and Creation
 
Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...
Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...
Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...
 
Part 2 Deep Dive: Navigating the 2024 Slowdown
Part 2 Deep Dive: Navigating the 2024 SlowdownPart 2 Deep Dive: Navigating the 2024 Slowdown
Part 2 Deep Dive: Navigating the 2024 Slowdown
 
Prescriptive analytics BA4206 Anna University PPT
Prescriptive analytics BA4206 Anna University PPTPrescriptive analytics BA4206 Anna University PPT
Prescriptive analytics BA4206 Anna University PPT
 
Ellen Burstyn: From Detroit Dreamer to Hollywood Legend | CIO Women Magazine
Ellen Burstyn: From Detroit Dreamer to Hollywood Legend | CIO Women MagazineEllen Burstyn: From Detroit Dreamer to Hollywood Legend | CIO Women Magazine
Ellen Burstyn: From Detroit Dreamer to Hollywood Legend | CIO Women Magazine
 
欧洲杯投注-欧洲杯投注外围盘口-欧洲杯投注盘口app|【​网址​🎉ac22.net🎉​】
欧洲杯投注-欧洲杯投注外围盘口-欧洲杯投注盘口app|【​网址​🎉ac22.net🎉​】欧洲杯投注-欧洲杯投注外围盘口-欧洲杯投注盘口app|【​网址​🎉ac22.net🎉​】
欧洲杯投注-欧洲杯投注外围盘口-欧洲杯投注盘口app|【​网址​🎉ac22.net🎉​】
 
欧洲杯赌球-欧洲杯赌球买球官方官网-欧洲杯赌球比赛投注官网|【​网址​🎉ac55.net🎉​】
欧洲杯赌球-欧洲杯赌球买球官方官网-欧洲杯赌球比赛投注官网|【​网址​🎉ac55.net🎉​】欧洲杯赌球-欧洲杯赌球买球官方官网-欧洲杯赌球比赛投注官网|【​网址​🎉ac55.net🎉​】
欧洲杯赌球-欧洲杯赌球买球官方官网-欧洲杯赌球比赛投注官网|【​网址​🎉ac55.net🎉​】
 
Call8328958814 satta matka Kalyan result satta guessing
Call8328958814 satta matka Kalyan result satta guessingCall8328958814 satta matka Kalyan result satta guessing
Call8328958814 satta matka Kalyan result satta guessing
 
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan ChartSatta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
 

CLO3 KEY PERFORMANCE INDICATORS.pptx

  • 1. Healthcare Operations Management Module Title : Healthcare Operations Management Level of Study : CIQ Level -7/ Postgraduate By Dr.Syed Raza, MD, MRCP,FRCP,CCT,FACC,FESC PG Dip. HCM , American Board in Medical Quality
  • 2. Objectives to cover (LO3) • 1.Clinical and non -clinical metrics to enhance organizational performance in healthcare setting • 2. Patient satisfaction and process enhancement leading to cost benefits • 3. Review of performance indicators • 4. Develop a model and recommend solutions for enhanced performance • 5. Team work
  • 3. Process and outcome measures Measures of healthcare performance can be process or outcomes measures. – Process measures answer the question, “Are we doing the right things?” – Outcomes measures answer the question, “Are we doing the right things well?”
  • 4. KPIs vs. Metrics: Know the Difference • A key performance indicator is used to measure performance and success. • A metric is nothing more than a number within a KPI that helps track performance and progress.
  • 5. Key Performance Indicator • Key Performance Indicator measures performance or outcome . • In a healthcare setting this is achieved by using clinical and non- clinical metrics
  • 7. Common metrics in Healthcare • Average Length of Stay • Time to service. • Hospital Incidents. • Patient Satisfaction. • Physician performance. • Patient readmission rate. • Operating Margin. • Bed Occupancy Rate.
  • 8. Common metrics in Healthcare • Patient Drug Cost per stay • Medical Utilization rate • Turn around time for medical reports • Waiting time • Staff to patient ratio • Cancelled / missed appointments
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16. A KPI should be based on the following principles: • Implement a specific objective for each KPI. • You must be able to measure your progress (or lack thereof) over a specific period of time. • The best KPIs are those that can be attained with a reasonable level of effort. • Results (such as the metrics you measure) should be related to your goals.
  • 17. • Indicators can measure structures, processes or outcomes of health care. • Clinical performance indicators are usually based on rates measured or significant (critical) incidents in patient population (ie. using clinical metrics) • Non-Clinical performance indicators are based on metrics that measures service delivery, operational cost, profit etc.
  • 18. What is hospital quality metrics ? Hospital quality metrics are a set of standards developed by CMS to quantify healthcare processes, patient outcomes, and organizational structures.
  • 19. Examples of clinical metrics in KPI • Average Length of Stay. • Hospital Incidents • Patient Satisfaction. • Physician performance. • Patient readmission rate
  • 20. Examples of non-clinical metrics • Hospital length of stay • Bed occupancy rate • Operational cost • Profit margin
  • 21. Sentinel Event Indicators An adverse sentinel event is defined as “an unexpected occurrence- involving death or serious physical or psychological injury, or the risk thereof”
  • 22. Rate based indicators • Unlike sentinel event indicators that identify single occurrences, rate-based indicators are used to monitor many events or a process over a specified period of time. Caesarean sections vaginal births after C-section Unexpected deaths Wound infections • Rate-based indicators measure the proportion of occurrences or events in relation to the population at risk. To determine the rate, divide the number of occurrences (numerator) by the number of individuals at risk (denominator)
  • 23. Required performance measures (JCIA) • 1. All adverse events or patterns of adverse events occurring during anesthesia use, including sedation of patients while the patients are conscious • 2. Processes and outcomes related to behavior management, including (when possible) the perceptions of the patients or individuals served, their families, and the hospital’s clinical staff • 3. Processes and outcomes related to the use of restraint and seclusion • 4. Appropriateness of admission and continued stays (i.e., utilization management activities) • 5. Significant adverse drug reactions
  • 24. Required performance measures : Contd1 • 6. Processes and outcomes related to medication usage • 7. Processes and outcomes related to surgery and invasive or noninvasive procedures • 8. Processes and outcomes related to blood usage • 9. Appropriateness, completeness, and timeliness of health record documentation • 10.Deficiencies, problems, failures, and user errors in safety management, life safety management, equipment management, and utilities management
  • 25. Required performance measures : Contd2 • 11. Information solicited from patients and mdividuals served, their families, hospital staff members, and others about how well the organization is meeting needs and expectations, the level of satisfaction with the organization, and areas where the organization could improve • 12. Competence of all staff, including licensed independent practitioners • 13. Risk-management activities • 14. Quality control activities covering the following services: clinical laboratory. nutrition, equipment used in administering medication, and pharmaceutical equipment used to prepare medication (only those services provided in the organization)
  • 26. PATIENT CENTERED STANDARDS • Access to Care & Continuity of Care (ACC) • • Patient & Family Rights (PFR). • • Assessment of Patient (AOP) • • Care of Patient (COP). • • Patient & Family Education (PFE)
  • 27. Healthcare Organization Management Standards • Quality Improvement and Patient Safety (QPS) • • Prevention and Control of Infection (PCI) • • Governance, Leadership and Direction (GLD) • • Facility Management and Safety (FMS) • • Staff Qualification and Management (SQE) • • Management of Information (MOI)
  • 28. Goal Metrics Metrics that organizations utilize to measure performance goal using or testing certain strategy or planning.
  • 34. The seven groupings of outcome measures CMS uses to calculate hospital quality are some of the most common in healthcare • #1: Mortality • #2: Safety of Care • #3: Readmissions • #4: Patient Experience • #5: Effectiveness of Care • #6: Timeliness of Care • #7: Data Transparency
  • 35. Why Measure? • To provide facts by which to manage • • To take advantage of the reality that people pay more attention to facts • • To help make decisions based on fact • • To help prioritize opportunities for improvement • • To recognize successes • • To evaluate performance
  • 36. Process and Outcomes Measures for Outpatients with Diabetes MelIittis • Process measures – Rate of glycosylated hemoglobin testing – Percent of patients self-monitoring of blood glucose – Rates of dilated ophthalmoscopic examination – Rates of foot examination • Outcome measures – Average value of glycosylated hemoglobin testing – Hospitalization rates – Percentage of patients developing foot ulcers
  • 37. Peri-operative Indicators • Denominator: All patients undergoing inpatient procedures involving anesthesia (defined as administration of general, spinal, or regional anesthesia or sedation) for which there is a reasonable expectation that the sedation anesthesia will result in the loss of protective reflexes for a significant percentage of patients (all settings, purposes, routes) 1. “Focus: Preoperative patient evaluation, intraoperative and postoperative monitoring, and timely clinical intervention Numerator: Patients developing a CNS complication occurring within two postprocedure days of procedures involving anesthesia administration (subcategorized by ASA-PS class, patient age, and CNS- versus non-CNSrelated procedures” 2. Focus: Same, plus appropriate surgical preparation “Numerator: Patients developing a peripheral neurological deficit within two postprocedure days of procedures involving anesthesia administration” 3. “Focus: Preoperative patient evaluation, intraoperative and postoperative monitoring, and timely clinical intervention Numerator: Patients developing an acute myocardial infarction within two post procedure days of procedures involving anesthesia administration [subcategorized by ASA-PS class, patient age, and cardiac- versus noncardiac-related procedures]” 4. Focus: Same “Numerator. Patients with a cardiac arrest within two postprocedure days of procedures involving anesthesia administration [subcategorized by ASA-PS class, patient age, and cardiac-versus noncardiac-related procedures]” 5. Focus Same “Numerator: Intrahospital mortality of patients within two postprocedure days of procedures involving anesthesia administration [subcategorized by ASA-PS class and patient age]
  • 38. Obstetrical care indicators • . Focus: Prenatal patient evaluation, education, and treatment selection Numerator: Patients delivered by cesarean section Denominator: All deliveries 7. Focus: Same Numerator: Patients with vaginal birth after cesarean section (VBAC) Denominator: Patients delivered with a history of previous cesarean section” 8. Focus: Prenatal patient evaluation, intrapartum monitoring, and clinical intervention Numerator. Live-born infants with a birthweight less than 2500 grams Denominator: All live births 9. Focus: Prenatal patient evaluation, intrapartum monitoring, neonatal patient eva1uatIc and clinical intervention Numerator. Live-born infants with a birthweight greater than or equal to 2500 grams, who have at least one of the following: anApgar score of less than 4 at five minutes, a requirement for admission to the neonatal intensive care unit within one day of delivery for greater than 24 hours, a dinically apparent seizure, or significant birth trauma Denominator: All five-born infants with a birthweight greater than 2500 grams* 10. Focus: Same “Numerator. Live-born infants with a birthweight greater than 1000 grams and less than 2500 grams who have an Apgar score of less than 4 at five minutes Denominator: All live-born infants with a birthweight greater than 1000 grams and less than 2500 gram
  • 39. Cardiovascular Indicators • Focus: Extended postoperative stay as a means of assessing multiple aspects of coronary artery bypass graft (CABG) care Indicator Statement: Patients undergoing isolated CABG procedures: number of days from- surgery to discharge Focus: Timing of thrombolytic therapy administration Indicator Statement: Patients admitted through the emergency department who have a principal discharge diagnosis of acute myocardial infarction (AM I) and ST segment evaluation on their initial electrocardiogram: time from emergency department arrival to administration of thrombotytic therapy “Focus: Diagnostic accuracy Numerator Patients with principal discharge diagnosis of congestive heart failure (CHF) with documented etiology Denomator Patients with principal discharge diagnosis of CHF “Focus: Extended postprocedure Stay as a means of assessing multiple aspects of percutaneous-transluminal coronary angioplasty (PTCA) care Indicator Statement: Patients undergoing PTCA: number of days from procedure to discharge “Focus: Intrahospital mortality as a means of assessing multiple aspects of coronary artery bypass graft (CABG) patient care Numeratoar Intrahospital mortality of patients undergoing an isolated CABG Denominator Patients undergoing an iso!ated CABGW “Focus: Intrahospital mortality as a means of assessing multiple aspects of percutaneous transluminal coronary angioplasty (PTCA) patient care Numerator: lntrahospital mortality of patients undergoing a PTCA Denominator: Patients undergoing PTCA “Focus: Intrahospital mortality as a means of assessing multiple aspects of acute myocardial infarction (AMI) patient care Numerator: Intrahospital mortality of patients with a principal discharge diagnosis of AMI Denominator: Patients with a principal discharge diagnosis of AMI”
  • 40. Oncology Indicators • “Focus: Availability of data for diagnosis and staging Numerator. Patients undergoing resection for primary cancer of the lung, colon/rectum or female breast for whom a surgical pathology consultation report is present in the medical record Denominator: Patients undergoing resection for primary cancer of the female breast, lung, or colon/ rectum. 17. “Focus: Use of staging by managing physicians Numerator: Patients undergoing resection for primary cancer of the female breast, or colon/ rectum with stage of tumor designated by a managing physician Denominator: Patients undergoing resection for primary cancer of the female breast, lung, of colon/rectums 18. “Focus: Use of tests critical for prognosis and clinical management of female breast cancer Numerator. Female patients with American Joint Committee on Cancer (AJCC) Stage I or greater primary breast cancer who, after initial biopsy or resection, have estrogen receptor analysis results in the medical record Denominator Female patients with Stage I or greater primary breast cancer undergoing initial biopsy or resection’ 19. “Focus: Effectiveness of preoperative diagnosis and staging Numerator. Patients with nonsmall cell primary lung cancer undergoing thoracotomy with complete surgical resection of tumor Denominator Patients with nonsmall cell primary lung cancer undergoing thoracotomy 20. “Focus: Comprehensiveness of diagnostic workup Numerator: Patients undergoing resection of primary cancer of the colon or rectum whose preoperative evaluation by a managing physician included examination of the entire colon Denominator: Patients undergoing resection for primary cancer of the colon or rectum.
  • 41. Medication use indicators • “Focus: Individualizing dosage Numerator lnpatients 65 years of age or older in whom creatinine clearance has been estimated or measured Denominator Inpatients 65 years of age or older 27 “Focus liming of medication administration - - Indicator Statement Patients with selected surgical procedures receiving intravenous prophylactic antibiotics Timing of prophylactic antibiotic administration 28 “Focus Informing the patient about the medication - Numerator lnpatients with a discharge diagnosis of insulin-dependent diabetes mellitus who demonstrate self-blood-glucose monitoring and self-administration of insulin before discharge or are referred for postdischarge follow-up for diabetes management Denominator: Inpatients with a discharge diagnosis of insuIin-dependent diabetes 29 a “Focus Monitoring patient response Numerator. Inpatients receiving digoxin who have no corresponding measure drug level or whose highest measured level exceeds a specific limit Denominator Inpatients receiving digoxin’ 29b “Focus Monitoring patient response Numerator lnpatients receiving theophylline who have no corresponding measured drug level or whose highest measured level exceeds a specific limit Denominator Inpatients receiving theophyllin 29 c “Focus Monitoring patient response Numerator: Inpatients receiving phenytoin who have no corresponding measured drug level or whose highest measured level exceeds a specific limit Denominator lnpatient receiving phenytoin ” 29 d “Focus: Monitoring patient response Numerator: Inpatients receiving lithium who have no corresponding measured drug level or whose highest measured level exceeds a specific limit Denominator inpatient receiving lithium” 30 “Focus Reviewing complete drug regimen Indicator Statement: Inpatients Number of prescribed medications at discharge”
  • 42. Infection control indicators • Focus: Surgical site infection Numerator: Selected inpatient and outpatient surgical procedures complicated by a surgical site infection Denominator: l’1umber of selected inpatient and outpatient surgical procedures” 2. Focus: Ventilator pneumonia Numerator: Ventilated inpatients who develop pneumonia Denominator: Inpatient ventilator days 3. Focus: Concurrent surveillance of primary bloodstream infection Numerator: Inpatients with a central or umbilical line who develop primary bloodstream infection Denominator. Inpatient central or umbilical line days
  • 43. Acute Care Indicators • Device-associated infections in the surgical intensive care unit • Device use in the surgical intensive care unit (central lines, ventilators, indwelling urinary catheters) • Surgical site infections • Prophylaxis [antibiotic] usage for surgical procedures • Total inpatient mortality (10 DRGs and all other DRGs) • Neonatal mortality (direct admissions and transfers) • Total perioperative mortality (Within 48 hours of anesthesia, by ASA class) • Management of pregnancy (cesarean sections and VBACs) • Unscheduled readmissions (within 15 and 31 days for 6 DRGs) • Unscheduled admissions following ambulatory procedure (inpatient and observation admissions) • Unscheduled returns to an intensive care unit Unscheduled returns to the operating room • Isolated CABG perioperative mortality (by ASA class, observed and expected) • Physical restraint use (total events, patients with multiple events, duration, reasons) • Documented falls (10 measures) • Complications following sedation and analgesia (4 areas)
  • 44. Acute care ambulatory indicators • • Unscheduled returns to the emergency department for same or related conçiition within the specified time frame (within 24 48 and/or 72 hours) • Registered patients’ time in the ED • ED x-ray discrepancies requiring a change in patient management • Registered patients leaving the ED before completing treatment Cancellation of ambulatory procedures on the day of the procedure
  • 45.
  • 46.
  • 48.
  • 49.
  • 50. What should be measured ? • What are the customers’ expectations? • What aspects of customer satisfaction should be measured? How can these aspects be measured? • For outcomes related to key quality attributes: What evidence is available to demonstrate whether the care or service provided have met the customers’ expectations and/or current professional standards? • Which outcomes are most important to our customers? • How can these be measured ?
  • 51.
  • 52.
  • 53.
  • 54. The Top Five Recommendations for Improving the Patient Experience of Care • #1: Use Patient Satisfaction as a Balance Measure—Not a Driver for Outcomes • #2: Evaluate Entire Care Teams—Not Individual Providers • #3: Use Healthcare Analytics to Understand and Act on Data • #4: Leverage Innovative Technology • #5: Improve Employee Engagement
  • 55.
  • 56.
  • 57.
  • 58.
  • 59.
  • 60.
  • 61.
  • 62.
  • 63.
  • 64.
  • 65.
  • 66.
  • 67.
  • 68.
  • 69.
  • 70.
  • 71.
  • 72.
  • 73.
  • 74.
  • 75.